Published on 08/04/2020

Each year, within its laboratory, the ANMV's Market Surveillance Unit verifies a series of veterinary medicinal products marketed in France.

Published on 08/04/2020

The veterinary medicinal product manufacturer ensures the quality of each batch before placing it on the market. However, there may be occasions when the manufacturer only becomes aware of an incident that occurred during manufacture or distribution after the medicinal product has been marketed. If the medicinal product does not comply with its marketing authorisation, this is known as a quality defect.

Published on 08/04/2020

ANSES-ANMV is responsible for controlling the advertising of veterinary medicinal products. For this reason, all advertising documents must be submitted to the Agency, and some even require authorisation, before being distributed. 

Published on 01/04/2020

Keywords : COVID-19

The emergence in China in late 2019 of a new coronavirus disease, COVID-19, and its rapid spread around the world have led researchers and health authorities to take prompt and widespread action to better understand the virus involved and how we can protect ourselves from it. It soon emerged that this virus, named SARS-CoV-2, is transmitted from person to person. In France, ANSES was asked to review the available scientific knowledge and assess the possibility of COVID-19 being transmitted via domestic animals or contaminated food. ANSES published its report on 11 March 2020. On the basis of the scientific knowledge available at the time, it concluded that there was no evidence that pets or farmed animals played any role in the spread of the disease. Furthermore, there is nothing to suggest that consumption of contaminated food can lead to infection via the digestive tract.

Published on 23/03/2020

Considering the rapidly changing health situation in France, all the staff of the French agency for veterinary medicinal products works remotely as of March 17th, 2020. Therefore, core safety functions shall remain available remotely. You can reach your regular contacts at  the French agency for veterinary medicinal products by e-mail or telephone. See the list of your contacts on the attached link.  

Updated on 08/04/2020

The French Agency for Veterinary Medicinal Products (ANSES-ANMV) is regularly called upon to qualify the legal status of products with regard to French and EU regulations and to determine whether these products, their placing on the market, their production and distribution fall within the scope of the regulations on veterinary medicinal products. To do this, ANSES-ANMV relies on the definition of a veterinary medicinal product according to European Directive 2001/82/EC as amended, which has been transposed into Articles L. 5111-1 and L. 5141-1 of the Public Health Code.

Updated on 08/04/2020

A batch recall is considered following identification of a quality defect or pharmacovigilance problem, or following a decision to suspend/revoke a marketing authorisation or temporary authorisation for use.

Updated on 08/04/2020

The aim of good laboratory practice is to guarantee the quality and integrity of data obtained in non-clinical trials carried out on veterinary medicinal products with a view to obtaining marketing authorisation, so that these data can be recognised internationally (in particular by OECD Member States) without the need to duplicate studies. GLP is a quality assurance system covering the way in which non-clinical safety studies relating to human and animal health and the environment are organised and the conditions under which these studies are planned, performed, monitored, recorded, reported, archived and disseminated.  

Published on 27/02/2020

Keywords : Plant health, Pinewood Nematode

The pinewood nematode (Bursaphelenchus xylophilus) is a microscopic worm that affects trees of the conifer family, especially maritime pine. It is a particularly destructive parasite responsible for severe dieback in pine forests. Transmitted by an insect vector, its spread is mainly due to the transport of wood or plants. If this parasite were introduced into France, the Landes area would be at risk due to the widespread presence of maritime pine. As the National and European Reference Laboratory for identification of the pinewood nematode, ANSES has conducted several expert appraisals to assess the risks of introduction and establishment of the organism in France and to recommend management measures for pine wood and bark.

Published on 25/02/2020

Keywords : Reference values (RVs)

As part of its missions and under the French National Environmental & Health Action Plan (2004-2008), the Agency began a national programme on TRVs in 2004 with the aim of building solid French expertise that could be shared by the various competent authorities in this area.